InsidersTradesSigma
Explore the complete record of transactions filed by Hoerter Steven L., Chief Executive Officer. Director active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 1 disclosures have been recorded. The latest transaction was filed on 21 March 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Steven L. Hoerter is the President and Chief Executive Officer of Deciphera Pharmaceuticals, Inc. He leads the company and oversees its overall strategy. His experience in the pharmaceutical sector is essential for the company's development.